MANILA- The Food and Drug Administration (FDA) has ordered the Belo Medical Group to stop selling some of its products after these were discovered to be unregistered with the regulator.
The agency took took this step after the company's clinic in Alabang, Muntinlupa allegedly sold mislabeled cosmetic products and unregistered drug products.
A surveillance video of a second test-buy operation conducted by FDA operatives showed a cashier of the clinic getting a product worth P22,000 from the pharmacy.
The FDA ordered Belo Medical Group to immediately stop selling the following products:
-ZO Medical by Zein Obagi;
-MD Glycogent Exfoliation Accelerator 10% concentration;
-ZO Medical by Zein Obagi Foamacleanse Gentle Foaming Cleanser for all types;
-ZO Medical by Zein Obagi Oclipse Sunscreen/Primer SPF 30 Protection;
-Belo Illuminating Cream Alpha Arbutin+Liquorice;
-Belo Prescriptives Keralyt 2 Cream;
- ZO Medical by Zein ObagiMD Melamix Skin Lightener & Blending Creme Hydroquinone USP 4%;
-ZO Medical by Zein Obagi MD Melanin Skin Bleaching & Correcting Creme Hydroquinone USP 4%;
-Belo Prescriptives Acne Astringent;
-Belo Prescriptives Belo White;
-Belo Prescriptives DLC Peeling Creme;
-ZO Medical by Zein Obagi MD Cebatrol.
The FDA said 11 drugs and cosmetic items they bought from Belo were not registered with them.
"Hindi dumaan sa registration process ng FDA, so ang ibig sabihin nun, kung hindi siya authorized, hihintayin niya dapat na dumaan doon sa proseso ng FDA, that they will be allowed to sell," retired Gen. Allen Bantolo, chief of the FDA Regulatory Enforcement Unit, said.
Bantolo said all drugs and cosmetic products should undergo certification from the FDA to ensure that these are safe for public use.
The Belo Clinic in Alabang resisted inspection of their clinic and pharmacy, which could lead to more serious charges against the firm.
"Even nga yung kanilang pharmacy na under jurisdiction ng aming FDA [hindi pina-inspect], when in fact, nasa batas din yon na they are supposed to allow inspectors for inspection. May provisions yan na pwede silang ma-contempt or obstruction of justice," Bantolo said.
In a statement, the Belo Medical Group said it will comply with the FDA and added that their products are safe.
"We have always ensured registration and renewal of registration of all our products. Hence, the inspection by FDA of one of our clinics is surprising and unfortunate," the statement read.
"We assure our customers and the public of the safety of our products and our compliance with regulatory standards. We are submitting to FDA proof that we have been compliant with their regulations."